These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38005928)

  • 1. Identification of Host Factors for Rift Valley Fever Phlebovirus.
    Balaraman V; Indran SV; Li Y; Meekins DA; Jakkula LUMR; Liu H; Hays MP; Souza-Neto JA; Gaudreault NN; Hardwidge PR; Wilson WC; Weber F; Richt JA
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of host factors for Rift Valley Fever Phlebovirus.
    Balaraman V; Indran SV; Li Y; Meekins DA; Jakkula LUMR; Liu H; Hays MP; Souza-Neto JA; Gaudreault NN; Hardwidge PR; Wilson WC; Weber F; Richt JA
    bioRxiv; 2023 Sep; ():. PubMed ID: 37808812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
    Ly HJ; Lokugamage N; Nishiyama S; Ikegami T
    PLoS One; 2017; 12(9):e0185194. PubMed ID: 28926632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rift Valley Fever Phlebovirus Reassortment Study in Sheep.
    Balaraman V; Indran SV; Kim IJ; Trujillo JD; Meekins DA; Shivanna V; Zajac MD; Urbaniak K; Morozov I; Sunwoo SY; Faburay B; Osterrieder K; Gaudreault NN; Wilson WC; Richt JA
    Viruses; 2024 May; 16(6):. PubMed ID: 38932172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein Phosphatase-1 regulates Rift Valley fever virus replication.
    Baer A; Shafagati N; Benedict A; Ammosova T; Ivanov A; Hakami RM; Terasaki K; Makino S; Nekhai S; Kehn-Hall K
    Antiviral Res; 2016 Mar; 127():79-89. PubMed ID: 26801627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Genome-Wide RNA Interference Screen Identifies a Role for Wnt/β-Catenin Signaling during Rift Valley Fever Virus Infection.
    Harmon B; Bird SW; Schudel BR; Hatch AV; Rasley A; Negrete OA
    J Virol; 2016 Aug; 90(16):7084-7097. PubMed ID: 27226375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Black rats (Rattus rattus) as potential reservoir hosts for Rift Valley fever phlebovirus: Experimental infection results in viral replication and shedding without clinical manifestation.
    Stoek F; Rissmann M; Ulrich R; Eiden M; Groschup MH
    Transbound Emerg Dis; 2022 May; 69(3):1307-1318. PubMed ID: 33794070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.
    Scharton D; Bailey KW; Vest Z; Westover JB; Kumaki Y; Van Wettere A; Furuta Y; Gowen BB
    Antiviral Res; 2014 Apr; 104():84-92. PubMed ID: 24486952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular aspects of Rift Valley fever virus and the emergence of reassortants.
    Gaudreault NN; Indran SV; Balaraman V; Wilson WC; Richt JA
    Virus Genes; 2019 Feb; 55(1):1-11. PubMed ID: 30426314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HSP90 is part of a protein complex with the L polymerase of Rift Valley fever phlebovirus and prevents its degradation by the proteasome during the viral genome replication/transcription stage.
    Alem F; Brahms A; Tarasaki K; Omole S; Kehn-Hall K; Schmaljohn CS; Bavari S; Makino S; Hakami RM
    Front Cell Infect Microbiol; 2024; 14():1331755. PubMed ID: 38800833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creation of Rift Valley fever viruses with four-segmented genomes reveals flexibility in bunyavirus genome packaging.
    Wichgers Schreur PJ; Oreshkova N; Moormann RJ; Kortekaas J
    J Virol; 2014 Sep; 88(18):10883-93. PubMed ID: 25008937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathogenesis of Rift Valley fever.
    Ikegami T; Makino S
    Viruses; 2011 May; 3(5):493-519. PubMed ID: 21666766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A strand-specific real-time quantitative RT-PCR assay for distinguishing the genomic and antigenomic RNAs of Rift Valley fever phlebovirus.
    Tercero B; Terasaki K; Nakagawa K; Narayanan K; Makino S
    J Virol Methods; 2019 Oct; 272():113701. PubMed ID: 31315022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NSs Protein Encoded by the Virulent Strain of Rift Valley Fever Virus Targets the Expression of Abl2 and the Actin Cytoskeleton of the Host, Affecting Cell Mobility, Cell Shape, and Cell-Cell Adhesion.
    Bamia A; Marcato V; Boissière M; Mansuroglu Z; Tamietti C; Romani M; Simon D; Tian G; Niedergang F; Panthier JJ; Flamand M; Souès S; Bonnefoy E
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33087469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.
    Ikegami T; Hill TE; Smith JK; Zhang L; Juelich TL; Gong B; Slack OA; Ly HJ; Lokugamage N; Freiberg AN
    J Virol; 2015 Jul; 89(14):7262-76. PubMed ID: 25948740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
    Terasaki K; Tercero BR; Makino S
    Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-cycle replicable Rift Valley fever phlebovirus vaccine carrying a mutated NSs confers full protection from lethal challenge in mice.
    Terasaki K; Juelich TL; Smith JK; Kalveram B; Perez DD; Freiberg AN; Makino S
    Sci Rep; 2018 Nov; 8(1):17097. PubMed ID: 30459418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RT-qPCR genotyping assays for differentiating Rift Valley fever phlebovirus strains.
    Balaraman V; Gaudreault NN; Trujillo JD; Indran SV; Wilson WC; Richt JA
    J Virol Methods; 2023 May; 315():114693. PubMed ID: 36801236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation.
    Ikegami T; Narayanan K; Won S; Kamitani W; Peters CJ; Makino S
    PLoS Pathog; 2009 Feb; 5(2):e1000287. PubMed ID: 19197350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral and protective effect of small interfering RNAs against rift valley fever virus in vitro.
    Ahmed EM; Boseila AA; Hanora AS; Solyman SM
    Mol Biol Rep; 2023 Jul; 50(7):5837-5848. PubMed ID: 37231214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.